文献速递慢性肾脏病

多因素强化干预对2型糖尿病患者糖尿病肾病有显著影响

Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes.
PubMed 文献 · Kidney Int · 2020-09-04

基于J-DOIT3队列2540例2型糖尿病患者,随机分为强化多因素干预组(1269例)和常规治疗组(1271例),中位治疗8.5年。预设肾脏结局为复合终点,强化治疗组肾脏事件显著减少32%,且与起始后1年HbA1c变化相关。

要点

  • 强化多因素干预(HbA1c<6.2%、血压<120/75 mmHg、LDL-C<80 mg/dL)显著减少肾脏事件。
  • 肾脏事件复合终点包括白蛋白尿进展、肌酐翻倍或肾衰竭,强化组发生181例,常规组257例。
  • 强化治疗组肾脏事件相对风险降低32%,且与1年HbA1c变化相关。

核心结论

  • 在2型糖尿病患者中,与指南推荐的常规治疗相比,强化多因素干预显著减少糖尿病肾病的发生和进展。

研究设计与样本

  • 基于J-DOIT3队列的随机对照研究,2540例合格患者随机分为强化治疗组(1269例)和常规治疗组(1271例),中位治疗8.5年。

主要发现

  • 共发生438例肾脏事件,强化治疗组181例,常规治疗组257例。
  • 强化治疗组肾脏事件风险较常规治疗组显著降低32%。
  • 强化治疗与起始后1年HbA1c变化相关。

关键数值与推荐

  • 强化治疗目标:HbA1c低于6.2%,血压低于120/75 mmHg,低密度脂蛋白胆固醇低于80 mg/dL。
  • 常规治疗目标:HbA1c低于6.9%,血压低于130/80 mmHg,低密度脂蛋白胆固醇低于120 mg/dL。
  • 预设肾脏结局为复合终点:正常白蛋白尿进展至微量或大量白蛋白尿、微量白蛋白尿进展至大量白蛋白尿、血清肌酐较基线翻倍或肾衰竭。

临床怎么用

  • 对2型糖尿病患者,可考虑强化多因素干预(血糖、血压、血脂严格控制)以延缓糖尿病肾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To evaluate the effect of multifactorial intervention on the onset and progression of diabetic kidney disease in the patients with type 2 diabetes, we analyzed the effects of intensified multifactorial intervention by step-wise intensification of medications and life-style modifications (intensive therapy treatment targets; HbA1c under 6.2%, blood pressure under 120/75 mmHg, low-density lipoprotein cholesterol under 80 mg/dL) comparing with the guideline-based standard care (conventional therapy treatment targets: HbA1c under 6.9%, blood pressure under 130/80 mmHg, low-density lipoprotein cholesterol under 120 mg/dL) on diabetic kidney disease. A total of 2540 eligible patients in the Japan Diabetes Optimal Integrated Treatment for three major risk factors of cardiovascular diseases (J-DOIT3) cohort were randomly assigned to intensive therapy (1269) and conventional therapy (1271) and treated for a median of 8.5 years. The prespecified kidney outcome measure was a composite of progression from normoalbuminuria to microalbuminuria or progression from normoalbuminuria to macroalbuminuria or progression from microalbuminuria to macroalbuminuria, serum creatinine levels elevated by two-fold or more compared to baseline, or kidney failure. Primary analysis was carried out on the intention-to-treat population. Changes in the estimated glomerular filtration rate and albuminuria were also analyzed. A total of 438 kidney events occurred (181 in the intensive therapy group and 257 in the conventional therapy group). Intensive therapy was associated with a significant 32% reduction in kidney events compared to conventional therapy and was associated with a change in HbA1c at one year from study initiation. Thus, prespecified analysis shows that intensified multifactorial intervention significantly reduced the onset and progression of diabetic kidney disease compared to currently recommended care.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ueki K, Sasako T, Okazaki Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2020. PMID: 32891604. doi:10.1016/j.kint.2020.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。